Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs

Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs

US Patent 8268617 · Granted Sep 18, 2012

Estimated economic value: $12,709,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD19 antibodies and uses therof2024
Method for increasing the efficacy of cancer therapy by administering an anti-FO2024
Anti-CD123 antibodies and conjugates and derivatives thereof2024
Conjugates comprising cell-binding agents and cytotoxic agents2023
Methods for preparing a purified maytansinoid conjugate in a solution2022
CD37-binding molecules and immunoconjugates thereof2022
Anti-CD123 antibodies and conjugates and derivatives thereof2022
Method for identifying an ovarian cancer in a subject likely to respond to anti-2021
Antibodies and assays for detection of CD372021
Cross-linkers and their uses2021
Conjugates comprising cell-binding agents and cytotoxic agents2021
Anti-CD123 antibodies and conjugates and derivatives thereof2021